MENU
VTGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
VistaGen Therapeutics (VTGN) Earnings Date & Reports
Vistagen Therapeutics Inc is a biotechnology firm... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
VTGN is expected to report earnings to fall 44.44% to -25 cents per share on August 06
Q2'26
Est.
$-0.25
Q4'25
Beat
by $0.28
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.41
The last earnings report on February 12 showed earnings per share of -44 cents, beating the estimate of -73 cents. With 546.82K shares outstanding, the current market capitalization sits at 27.38M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of embryonic stem cells for drug discovery and development
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com